BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28395809)

  • 1. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
    Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():70-72. PubMed ID: 28395810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
    Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
    Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Isogenic Human Cell-Based System for MEN1 Syndrome Generated by CRISPR/Cas9 Genome Editing.
    Klementieva N; Goliusova D; Krupinova J; Yanvarev V; Panova A; Mokrysheva N; Kiselev SL
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.
    Bara AM; Messana A; Herring A; Hazelbaker DZ; Eggan K; Barrett LE
    Stem Cell Res; 2016 Sep; 17(2):441-443. PubMed ID: 27879221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
    Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
    Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20.
    Shetty DK; Inamdar MS
    Stem Cell Res; 2016 Mar; 16(2):207-9. PubMed ID: 27345969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9.
    Herring A; Messana A; Bara AM; Hazelbaker DZ; Eggan K; Barrett LE
    Stem Cell Res; 2016 Sep; 17(2):430-432. PubMed ID: 27879218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39.
    Shetty DK; Inamdar MS
    Stem Cell Res; 2016 Mar; 16(2):308-10. PubMed ID: 27345991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
    Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
    Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
    Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
    Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human iPSCs from urine derived cells of a non-affected control subject.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
    Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2.
    Wongkummool W; Maneepitasut W; Tong-Ngam P; Tangprasittipap A; Munkongdee T; Boonchuay C; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():80-83. PubMed ID: 28395745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an Abcc8 heterozygous mutation human embryonic stem cell line using CRISPR/Cas9.
    Guo D; Liu H; Gao G; Ruzi A; Wang K; Wu H; Lai K; Liu Y; Yang F; Lai L; Li YX
    Stem Cell Res; 2016 Nov; 17(3):670-672. PubMed ID: 27934605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene.
    Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
    Stem Cell Res; 2016 Sep; 17(2):273-276. PubMed ID: 27879211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
    Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
    Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.